Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Sackner-Bernstein

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Parkinson'S Disease|May 24, 2021
Estimates of Intracellular Dopamine in Parkinson's Disease: A Systematic Review and Meta-AnalysisJonathan Sackner-Bernstein
JAMA|September 11, 2003
The JNC 7 hypertension guidelinesJonathan Sackner-Bernstein
Journal of Diabetes Science and Technology|November 13, 2016
Design of Hack-Resistant Diabetes Devices and Disclosure of Their Cyber SafetyJonathan Sackner-Bernstein
Journal of Neurology|June 21, 2024
Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?Jonathan Sackner-Bernstein
JAMA|April 12, 2017
FDA Approval of Eteplirsen for Muscular DystrophyJonathan Sackner-Bernstein
Clinical Cardiology|February 3, 2006
Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapyJonathan Sackner-Bernstein
Coronary Artery Disease|March 17, 2004
What is the role of biventricular pacing the transplant candidate?Jonathan Sackner-Bernstein, D Michael Farmer
Current Cardiology Reports|May 2, 2007
Nesiritide for acute decompensated heart failure: does the benefit justify the risk?Jonathan Sackner-Bernstein, Keith D Aaronson
The New England Journal of Medicine|October 7, 2005
Nesiritide--not verifiedJonathan Sackner-Bernstein, Keith D Aaronson
JAMA|September 28, 2006
Risk of death associated with nesiritide in patients with acutely decompensated heart failureKeith D Aaronson, Jonathan Sackner-Bernstein
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Parkinson'S Disease|May 24, 2021
Estimates of Intracellular Dopamine in Parkinson's Disease: A Systematic Review and Meta-AnalysisJonathan Sackner-Bernstein
JAMA|September 11, 2003
The JNC 7 hypertension guidelinesJonathan Sackner-Bernstein
Journal of Diabetes Science and Technology|November 13, 2016
Design of Hack-Resistant Diabetes Devices and Disclosure of Their Cyber SafetyJonathan Sackner-Bernstein
Journal of Neurology|June 21, 2024
Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?Jonathan Sackner-Bernstein
JAMA|April 12, 2017
FDA Approval of Eteplirsen for Muscular DystrophyJonathan Sackner-Bernstein
Clinical Cardiology|February 3, 2006
Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapyJonathan Sackner-Bernstein
Coronary Artery Disease|March 17, 2004
What is the role of biventricular pacing the transplant candidate?Jonathan Sackner-Bernstein, D Michael Farmer
Current Cardiology Reports|May 2, 2007
Nesiritide for acute decompensated heart failure: does the benefit justify the risk?Jonathan Sackner-Bernstein, Keith D Aaronson
The New England Journal of Medicine|October 7, 2005
Nesiritide--not verifiedJonathan Sackner-Bernstein, Keith D Aaronson
JAMA|September 28, 2006
Risk of death associated with nesiritide in patients with acutely decompensated heart failureKeith D Aaronson, Jonathan Sackner-Bernstein
Pageof 2